Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keigo Kihara

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2026
[Botulism in Japan]Keigo Kihara, Hideki Mochizuki
Frontiers in Immunology|March 13, 2023
Single-cell RNA-seq analysis identifies distinct myeloid cells in a case with encephalitis temporally associated with COVID-19 vaccinationMasakazu Ishikawa, Yuki Shimada, Tatsuhiko Ozono, et al.
Clinical Neurology and Neurosurgery|June 20, 2024
Switching disease-modifying therapies from sphingosine-1-phosphate receptor modulators to natalizumab or dimethyl fumarate restores immune responses after SARS-CoV-2 mRNA vaccination in patients with multiple sclerosisMinami Kanakura, Keigo Kihara, Makoto Kinoshita, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 20, 2023
Adult-onset botulism in a Japanese woman with prolonged spore excretionKeigo Kihara, Yuta Kajiyama, Yasuyoshi Kimura, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 25, 2022
Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum DisorderHisashi Murata, Makoto Kinoshita, Yoshiaki Yasumizu, et al.
Frontiers in Immunology|February 18, 2025
Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid taperingRyohei Yamamura, Makoto Kinoshita, Yoshiaki Yasumizu, et al.
Scientific Reports|January 8, 2022
High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD)Shohei Beppu, Makoto Kinoshita, Jan Wilamowski, et al.
Science Advances|November 22, 2023
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALSMikito Shimizu, Naoyuki Shiraishi, Satoru Tada, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2026
[Botulism in Japan]Keigo Kihara, Hideki Mochizuki
Frontiers in Immunology|March 13, 2023
Single-cell RNA-seq analysis identifies distinct myeloid cells in a case with encephalitis temporally associated with COVID-19 vaccinationMasakazu Ishikawa, Yuki Shimada, Tatsuhiko Ozono, et al.
Clinical Neurology and Neurosurgery|June 20, 2024
Switching disease-modifying therapies from sphingosine-1-phosphate receptor modulators to natalizumab or dimethyl fumarate restores immune responses after SARS-CoV-2 mRNA vaccination in patients with multiple sclerosisMinami Kanakura, Keigo Kihara, Makoto Kinoshita, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 20, 2023
Adult-onset botulism in a Japanese woman with prolonged spore excretionKeigo Kihara, Yuta Kajiyama, Yasuyoshi Kimura, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 25, 2022
Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum DisorderHisashi Murata, Makoto Kinoshita, Yoshiaki Yasumizu, et al.
Frontiers in Immunology|February 18, 2025
Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid taperingRyohei Yamamura, Makoto Kinoshita, Yoshiaki Yasumizu, et al.
Scientific Reports|January 8, 2022
High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD)Shohei Beppu, Makoto Kinoshita, Jan Wilamowski, et al.
Science Advances|November 22, 2023
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALSMikito Shimizu, Naoyuki Shiraishi, Satoru Tada, et al.
Pageof 1